A detailed history of California State Teachers Retirement System transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 128,415 shares of AUPH stock, worth $969,533. This represents 0.0% of its overall portfolio holdings.

Number of Shares
128,415
Previous 134,740 4.69%
Holding current value
$969,533
Previous $769,000 22.37%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.32 - $7.33 $33,649 - $46,362
-6,325 Reduced 4.69%
128,415 $941,000
Q2 2024

Aug 14, 2024

SELL
$4.81 - $5.78 $7,445 - $8,947
-1,548 Reduced 1.14%
134,740 $769,000
Q1 2024

May 15, 2024

SELL
$4.93 - $9.31 $36,053 - $68,084
-7,313 Reduced 5.09%
136,288 $682,000
Q4 2023

Feb 13, 2024

SELL
$7.13 - $9.49 $45,853 - $61,030
-6,431 Reduced 4.29%
143,601 $1.29 Million
Q3 2023

Nov 14, 2023

SELL
$7.77 - $12.27 $61,592 - $97,264
-7,927 Reduced 5.02%
150,032 $1.17 Million
Q2 2023

Aug 21, 2023

BUY
$8.96 - $11.69 $17,319 - $22,596
1,933 Added 1.24%
157,959 $1.53 Million
Q1 2023

May 09, 2023

SELL
$5.94 - $11.27 $13,240 - $25,120
-2,229 Reduced 1.41%
156,026 $1.71 Million
Q4 2022

Feb 14, 2023

BUY
$4.11 - $8.14 $6,608 - $13,089
1,608 Added 1.03%
158,255 $683,000
Q3 2022

Nov 18, 2022

BUY
$6.66 - $12.39 $35,337 - $65,741
5,306 Added 3.51%
156,647 $1.18 Million
Q2 2022

Aug 15, 2022

BUY
$8.95 - $12.8 $506,999 - $725,094
56,648 Added 59.82%
151,341 $1.52 Million
Q1 2022

May 16, 2022

BUY
$10.05 - $22.48 $23,908 - $53,479
2,379 Added 2.58%
94,693 $1.17 Million
Q4 2021

Feb 15, 2022

BUY
$17.78 - $33.08 $149,209 - $277,607
8,392 Added 10.0%
92,314 $2.11 Million
Q3 2021

Nov 15, 2021

BUY
$10.93 - $23.55 $917,267 - $1.98 Million
83,922 New
83,922 $1.86 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.07B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.